Latest MENOPUR Stories
PARSIPPANY, N.J., March 19, 2014 /PRNewswire-USNewswire/ -- Ferring Pharmaceuticals Inc. today announced FDA approval of new labeling for their fertility products, MENOPUR and BRAVELLE.
PARSIPPANY, N.J., April 25, 2011 /PRNewswire/ -- Celebrating National Infertility Awareness Week, April 24-30, 2011, Ferring Pharmaceuticals Inc.
AMSTERDAM, The Netherlands, June 30 /PRNewswire/ -- - "Study Could Have Major Impact on the Decision-Making Process With Respect to Infertility Treatment" New data from an economic analysis presented today at this year's European Society of Human Reproduction and Embryology (ESHRE) congress showed that, within the parameters of the simulation model used, the in vitro fertilisation (IVF) treatment MENOPUR (highly-purified human menopausal gonatropin or HP-hMG) offered considerable...
PARSIPPANY, N.J., Sept. 29 /PRNewswire/ -- Ferring Pharmaceuticals today announced a new, expanded cost-saving program for patients who are considering fertility treatment, but find the costs a challenge.
- A serpent whose bite was fabled to produce intense thirst.